Page last updated: 2024-08-24

telmisartan and Constriction, Pathologic

telmisartan has been researched along with Constriction, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alter, ML; Chaykovska, L; Hocher, B; Hohmann, M; Klein, T; Kraft, R; Kutil, B; Reichetzeder, C; Tsuprykov, O; von Websky, K1
Jaggi, AS; Singh, N1

Other Studies

2 other study(ies) available for telmisartan and Constriction, Pathologic

ArticleYear
Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
    Journal of hypertension, 2013, Volume: 31, Issue:11

    Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cardiomegaly; Collagen Type I; Constriction, Pathologic; Cystatin C; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Fibrosis; Heart; Hypertension, Renovascular; Kidney; Linagliptin; Lipoproteins, LDL; Male; Oxidative Stress; Purines; Quinazolines; Random Allocation; Rats; Rats, Wistar; Surgical Instruments; Telmisartan

2013
Exploring the potential of telmisartan in chronic constriction injury-induced neuropathic pain in rats.
    European journal of pharmacology, 2011, Sep-30, Volume: 667, Issue:1-3

    Topics: Animals; Behavior, Animal; Benzimidazoles; Benzoates; Constriction, Pathologic; Female; Foot Deformities; Hyperalgesia; Male; Neuralgia; Rats; Rats, Wistar; Telmisartan; Tumor Necrosis Factor-alpha

2011